HCP and Patient Targeting
Accurately Identify Patients and Their HCPs, Even for Rare and Hard-to-Diagnose Conditions
- Patient Finding and Targeting: Identify high-value patients and their treating providers at the right time in the patient journey to improve outcomes.
- Accurate Market Size Analysis: Understand the true prevalence and distribution of rare and hard-to-diagnose conditions for better strategic planning.
- Risk Stratification with Real-World Data: Hyper-segment patients using clinical notes, lab results, EMR data, and other real-world data.
- Comprehensive Patient Journey Insights: Correlate treatment patterns with HCP behavior and sentiment, payer coverage, site-of-care trends, and other factors to uncover actionable insights across the patient journey.
Start Targeting the Right Patients and Providers Today
What Our Clients Are Saying
“Our partnership with MMIT/Norstella was extremely valuable in providing a comprehensive, robust view of the patient burden for a rare disease. Using their comprehensive EHR and open and closed claims data, along with innovative AI and LLM techniques and agents, we were able to complete what we believe to be the most in-depth review of patient numbers ever conducted for this rare disease in the U.S. The MMIT team was proactive and passionate about their work and a great partner in delivering above and beyond the initial brief.”
Chief Commercial Officer
Cell and Gene Biotech Company
How We Can Help
We pinpoint the patients and HCPs that matter most—when it matters most. This enables your team to act with precision, improve engagement, and maximize impact.
HCP and Patient Targeting helps you find the right patients and treating HCPs by using integrated real world data to pinpoint high value populations and the providers most likely to manage them.
HCP and Patient Targeting improves the timing and precision of outreach by identifying when patients and providers are most likely to engage based on real world treatment patterns and care journey signals.
HCP and Patient Targeting optimizes your targeting strategy by combining clinical, claims, and provider level insights to refine segmentation and drive more effective, data driven engagement.
Key Insights From MMIT
Data That Delivers: Real-World Insights in Action
Real-world insights in healthcare are transforming how pharmaceutical manufacturers understand patient journeys, provider behavior, and payer decision-making.
NorstellaLinQ: Complex Cohort Identification Fuels Real-Time HCP Targeting
Learn how one manufacturer used integrated claims, lab, EMR and coverage data to identify newly diagnosed, early-stage cancer patients for just-in-time HCP targeting.
Solutions to Support Your Strategy
Enhance your targeting with complementary solutions that expand visibility into real world patient populations, treating providers, and payer dynamics to strengthen audience precision. Empower your team to act on integrated insights with greater confidence, accuracy, and impact.
Unstructured Data
MMIT and its parent company Norstella transform physician clinical notes, specialty consultations and other unstructured EMR notes into longitudinal, analytic-ready data.
RWD Visualizations
MMIT’s RWD Visualizations solution combines coverage data and claims data to provide commercial pharma teams with a unique view of payer and prescriber behavior.
RWD Insights
Use Norstella proprietary datasets to evaluate key business questions and objectives, conduct deeper data, and create a report with insights layered into each analysis and the overall implications to your strategy.